Literature DB >> 9561507

The risk of genital edema after external pump compression for lower limb lymphedema.

M Boris1, S Weindorf, B B Lasinski.   

Abstract

In a single lymphedema treatment facility, 128 consecutive patients with lower limb lymphedema were retrospectively analyzed for the development of genital edema. The patients were separated for analysis on the basis of who used or did not use compressive pump therapy. Of the 128 patients with lower limb lymphedema, 75 received no pump therapy, and 53 used pumps. Of the 75 who did not use pump compression, only 2 had genital edema. Of the 53 patients who used pump compression, 23 patients developed genital edema after pump therapy (p < .0001). The incidence of genital edema was unaffected by age, sex, grade or duration of lymphedema, whether lymphedema was primary or secondary, whether a single or sequential pump was used, the pressure level applied, or duration or hours per day of pump therapy. Compressive pump therapy for lower limb lymphedema produces an unacceptably high incidence of genital edema.

Entities:  

Mesh:

Year:  1998        PMID: 9561507

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  7 in total

Review 1.  [S1 guideline on intermittent pneumatic compression (IPC)].

Authors:  C Schwahn-Schreiber; F X Breu; E Rabe; I Buschmann; W Döller; G R Lulay; A Miller; E Valesky; S Reich-Schupke
Journal:  Hautarzt       Date:  2018-08       Impact factor: 0.751

2.  The effectiveness of intermittent pneumatic compression in long-term therapy of lymphedema of lower limbs.

Authors:  Marzanna Zaleska; Waldemar L Olszewski; Marek Durlik
Journal:  Lymphat Res Biol       Date:  2014-06       Impact factor: 2.589

3.  Advanced pneumatic therapy in self-care of chronic lymphedema of the trunk.

Authors:  Sheila H Ridner; Barbara Murphy; Jie Deng; Nancy Kidd; Emily Galford; Mary S Dietrich
Journal:  Lymphat Res Biol       Date:  2010-12       Impact factor: 2.589

4.  Effectiveness of the treatment-phase of two-phase complex decongestive physiotherapy for the treatment of extremity lymphedema.

Authors:  Ritsu Yamamoto; Terumi Yamamoto
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

5.  Lymphoedema: Pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programmes.

Authors:  Babar Vaqas; Terence J Ryan
Journal:  Filaria J       Date:  2003-03-12

6.  Risks and contraindications of medical compression treatment - A critical reappraisal. An international consensus statement.

Authors:  Eberhard Rabe; Hugo Partsch; Nick Morrison; Mark H Meissner; Giovanni Mosti; Christopher R Lattimer; Patrick H Carpentier; Sylvain Gaillard; Michael Jünger; Tomasz Urbanek; Juerg Hafner; Malay Patel; Stephanie Wu; Joseph Caprini; Fedor Lurie; Tobias Hirsch
Journal:  Phlebology       Date:  2020-03-02       Impact factor: 1.740

7.  Development of a framework for pneumatic device selection for lymphedema treatment.

Authors:  Sonja M Maul; Julie A Devine; Carolyn R Wincer
Journal:  Med Devices (Auckl)       Date:  2009-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.